We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Head and neck
Poster (digital)
Clinical
NLR and PLR ratio as predictive markers of outcomes in head and neck squamous cell carcinoma
Lucrezia Gasparini, Italy
PO-1073
Prognostic factors analysis of carcinoma ex pleomorphic adenoma of major salivary glands
Yu Hsuan Chang, Taiwan
PO-1074
Results of Concurrent SBRT and Immunotherapy in Recurrent and Metastatic Head and Neck Cancer
Melek Tugce Yilmaz, Turkey
PO-1075
Do patients with rmHNC treated with checkpoint inhibitors benefit form additional radiotherapy?
Bálint Tamaskovics, Hungary
PO-1076
Evaluation of Vascular and Nerve Changes in Nasopharyngeal Carcinoma Patients Following Radiotherapy
Meltem Dağdelen, Turkey
PO-1077
Obesity potential biomarker for prediction of OS in head and treated with radio-chemotherapy
Giovanni Gadducci, Italy
PO-1078
An optimal assessment schedule in the head and neck cancer using parametric modeling
Hye In Lee, Korea Republic of
PO-1079
Dosimetric Evaluation of Risk of Osteoradionecrosis (DERO): setting-up and first results.
Marion Renouf, France
PO-1080
BMI and SMI variations in HNSCC patients undergoing radiotherapy and nutritional intervention
Federico Mastroleo, Italy
PO-1081
CECT vs. MRI: Impact of concordance index for gross target volume in IMRT of head and neck cancers
Pallavi Kalbande, India
PO-1082
Sleep disturbances in head and neck cancer survivors one year after radiation therapy.
Vanessa Jerviz Guia, Spain
PO-1083
Relapse pattern in relation to FDG-PET and target volumes in HPV positive/negative oropharynx cancer
Katrin Håkansson, Denmark
PO-1084
Impact of multidisciplinary target review in head and neck radiation
Kaoutar SOUSSY, Morocco
PO-1085
Head and neck cancer of unknown primary: recurrence pattern based on treatment volumes
Annamaria Guaineri , Italy
PO-1086
Tumour volume response to induction chemotherapy in nasopharyngeal carcinoma: TPF versus GP
Omar Nouri, Tunisia
PO-1087
TOXICITY PROFILE OF 100 OROPHARYNGEAL CANCER PATIENTS TREATED WITH MODERN APPROACHES
Daniela Alterio, Italy
PO-1088
Antibiotic use goes along with reduced survival in head-and-neck cancer patients after radiotherapy
Alexander Rühle, Germany
PO-1089
Late toxicity-related symptoms and fraction dose affect decision regret in HNC patients
Muemtaz Koeksal, Germany
PO-1090
GTV as prognostic marker in head and neck cancer - Time to redefine GTV beyond contouring
Imtiaz Ahmed, India
PO-1091
Clinical implication of different treatment techniques in glottic cancer
Laura Cardoso Rubio, Spain
PO-1092
Effect of primary tumor volume on the clinical outcomes of nasopharyngeal carcinoma
Asim Hafiz, Pakistan
PO-1093
Long term outcomes of 630 consecutive patients of oropharyngeal cancer treated with radiotherapy
Ashwini Budrukkar, India
PO-1094
pre-treatment salivary flow predicts recovery of salivary flow after IMRT for head and neck cancer
Shinya Hiraoka, Japan
PO-1095
Long-term results of postoperative radiochemotherapy with weekly cisplatin in head and neck cancer
VICTOR DUQUE-SANTANA, Spain
PO-1096
Helium-Neon laser to treat radiation induced oral mucositis in oral cancer- A comparative study
Tasneem Nalawala, India
PO-1097
Head and neck cancer mastication structure doses by older and newer external beam RT techniques
Niclas Pettersson, Sweden
PO-1098
Split course hypofractionated radiotherapy in elderly and frail patients with head and neck cancers.
Karol Paciorek, Poland
PO-1099
Impact of sarcopenia in oropharyngeal cancer patients treated with radical chemo-radiotherapy
chiara lucrezia deantoni, Italy
PO-1100
Early NGT insertion prevents weight loss & treatment breaks in post-op CTRT and QoL assessment.
ajay gv, India
PO-1101
Effect of bio adhesive barrier forming oral liquid on radiation induced Oral mucositis HNSCC
Ashalatha Devalla, India
PO-1102
Results of postoperative radiotherapy in salivary gland tumors: a 10-years’ experience
Olga Engel, Spain
PO-1103
Impact of pre-treatment inflammatory markers in head and neck cancer treated with chemoradiotherapy
Deep Shankar Pruthi, India
PO-1104
Prognostic analysis of different T classification in N3 nasopharyngeal carcinoma patients
Shao-Wei Chiang, Taiwan
PO-1105
HPV Status and Fitness Associated With Aspiration Risk at One Year After Head and Neck Radiotherapy
Eliana Maria Vasquez Osorio, United Kingdom
PO-1106
miR-9 as predictor of response to Radiotherapy and Cetuximab in patients with head and neck cancers
Giuseppe Fanetti, Italy
PO-1107
Predicting radiation-induced neurocognitive decline in patients with brain or head & neck tumor
Fariba Tohidinezhad, The Netherlands
PO-1108
Treatment outcomes for HPV-associated tonsillar cancer: a single-institution experience of 374 cases
Joongyo Lee, Korea Republic of
PO-1109
Survival outcomes in Hypopharyngeal Squamous Cell Cancers in the West of Scotland Cancer Network
Wai-Yan Poon, United Kingdom
PO-1110
Hypoxia and Perfusion MR-Imaging on the MR-Linear Accelerator for Head and Neck Cancer
Amit Gupta, United Kingdom
PO-1111
Relationship between weight loss during IMRT and outcomes in patients with head and neck cancer
Kenji Makita, Japan
PO-1112
Predictive Factors for Response to Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer
Jens von der Grün, Switzerland
PO-1113
Intensity Modulated Radiotherapy (IMRT) after conservative surgery for supraglottic tumours
Daniela Alterio, Italy
PO-1114
First year survival data on COVID-19 outbreak during radiotherapy course in head and neck cancer
Anna Bandurska-Luque, Poland
PO-1115
Towards Privacy-Preserving Federated Deep Learning infrastructure : proof-of-concept
Chong Zhang, The Netherlands
PO-1116
Clinical and pathological prognostic factors in postoperative locally advanced head and neck cancer
Jose Antonio Domínguez Rullán, Spain
PO-1117
PTV changes analysis throughout treatment in H&N patients
Laura Cardoso Rubio, Spain
PO-1118
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Korea Republic of
PO-1119
The potential value of MRI in response evaluation after primary (C-)RT for head and neck cancer
Sandy Mohamed, Egypt
PO-1120
Acoustic analysis of voluntary and reflexive coughs in healthy subjects
Sofiana Mootassim-Billah, Belgium
PO-1121
Prospective assessment of diurnal variation of Xerostomia in treated head neck cancer (HNC) patients
Sharmila Agarwal, India
PO-1122